Title of article :
Hyperinsulinemia during oral glucose tolerance test is associated with increased neointimal tissue proliferation after coronary stent implantation in nondiabetic patients: A serial intravascular ultrasound study
Author/Authors :
Tsutomu Takagi، نويسنده , , Kiyoshi Yoshida، نويسنده , , Takashi Akasaka، نويسنده , , Shuichiro Kaji MD، نويسنده , , Takahiro Kawamoto، نويسنده , , Yasuhiro Honda، نويسنده , , Atsushi Yamamuro، نويسنده , , Takeshi Hozumi، نويسنده , , Shigefumi Morioka، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2000
Pages :
8
From page :
731
To page :
738
Abstract :
OBJECTIVES The purpose of this study was to determine whether hyperinsulinemia during the oral glucose tolerance test is associated with increased neointimal tissue proliferation after coronary stent implantation in nondiabetic patients. BACKGROUND Although hyperinsulinemia induces increased vascular smooth muscle cell proliferation in experimental models, it has not been determined whether hyperinsulinemia is associated with increased neointimal tissue proliferation after coronary stent implantation. METHODS Serial (postintervention and six-month follow-up) intravascular ultrasound (IVUS) was used to study 67 lesions treated with Palmaz-Schatz stents in 55 nondiabetic patients. Cross-sectional images within stents were taken at every 1 mm, using an automatic pullback, and a neointimal index was calculated as the ratio between the averaged neointimal area and averaged stent area. All patients underwent a 75-g oral glucose tolerance test. Plasma glucose (PG) and immunoreactive insulin (IRI) levels were measured at baseline and 1 and 2 h after the glucose load. The sum of PGs (ΣPG) and the sum of IRIs (ΣIRI) were calculated. Body mass index (BMI), lipid levels, and glycosylated hemoglobin levels were measured. RESULTS There were 27 patients with normal glucose tolerance, and 28 patients with impaired glucose tolerance (IGT). The neointimal index in patients with IGT was greater than that in patients with normal glucose tolerance (42.9 ± 14% vs. 24.9 ± 8.3%, respectively, p < 0.0001). Linear regression analysis showed that the neointimal index at follow-up correlated well with ΣPG (p < 0.0001), fasting IRI (p < 0.0001), ΣIRI (p < 0.0001), triglyceride level (p = 0.018), and BMI (p < 0.0001). Multiple regression analysis revealed that ΣIRI (p = 0.0002) and ΣPG (p = 0.0034) were the best predictors of the greater neointimal index at follow-up. CONCLUSIONS Serial IVUS assessment shows that hyperinsulinemia during an oral glucose tolerance test is associated with increased neointimal tissue proliferation after coronary stent implantation in nondiabetic patients.
Keywords :
Impaired glucose tolerance , Vascular smooth muscle cell , IRI , immunoreactive insulin level , MLA , minimal lumen area , MLD , minimal lumen diameter , BMI , NIDDM , body mass index , Non-insulin-dependent diabetes mellitus , DM , OGTT , glycosylated hemoglobin level , plasma glucose level , diabetes mellitus , Oral glucose tolerance test , HbA1C , PG , intravascular ultrasound , IGT , VSMC , IVUS
Journal title :
JACC (Journal of the American College of Cardiology)
Serial Year :
2000
Journal title :
JACC (Journal of the American College of Cardiology)
Record number :
596069
Link To Document :
بازگشت